Table 1.
Representative list of human-specific genetic changes linked to phenotypes
Genetic feature | Type of change | Evolutionary relevance | Proposed mechanism | Phenotypic impact | Refs. |
---|---|---|---|---|---|
AMY1 | Copy number change | Polymorphic in human populations | Higher copy number of AMY1 leads to enhanced starch degradation through amylase enzyme activity in salivary glands | Increased starch digestion capacity correlated with gene copy number and salivary amylase levels | 25 |
AQP7 | Copy number change | Human specific | Increased water and glycerol transport | Might augment endurance running in humans | 75 |
ARHGAP11B | Segmental duplication | Human specific | Loss of Rho GAP activity owing to a change in splice site | Basal progenitor amplification and neocortex expansion in mouse and marmoset models | 165,166,168 |
BOLA2 | Segmental duplication | Human specific | Correlation of gene copy number with RNA expression and protein levels | Iron homeostasis and susceptibility to anaemia | 297,298 |
CCL3L1 | Segmental duplication | Polymorphic in humans | HIV-1-suppressing chemokine | Lower copy numbers associated with AIDS susceptibility | 299 |
CMAH | Pseudogene | Human specific | 92-bp deletion in sialic acid hydroxylase domain leads to inactivation of enzyme activity that converts CMP-Neu5Ac into CMP-Neu5Gc | Atherosclerosis predisposition; xenosialitis through circulating anti-Neu5Gc; immunological changes; changes in muscle fatigue | 182,183,300–302 |
FOXP2 | Two single nucleotide substitutions positively selected (debated) | Human specific | Regulation of cortico-striatal circuit development | Involved in speech and language capability | 163,178,303 |
GHRD3 | Deletion of an exon | Human specific | Growth hormone receptor gene is affected | Associated with the response to nutritional defects along the evolutionary time course | 304 |
HACNS1 (HAR2) | Single nucleotide substitutions | Human specific | Regulates GBX2 expression (positively selected) | Associated with digit, limb and pharyngeal arch patterning | 155,159 |
HAR1 | Single nucleotide substitutions | Human specific | Modification of the primary sequence and secondary structure of a non-coding RNA gene | Expressed in Cajal–Retzius cells and other brain regions during development | 70 |
HYDIN2 | Segmental duplication | Human specific | Promoter modification altered tissue specificity of HYDIN2 isoforms in cerebellum and cerebral cortex | Potentially involved in neurodevelopmental disorders | 305 |
NBPF | Oludvai/DUF1220 protein domain copy number change | Human specific | DUF1220 domain dosage-associated increase in neural stem cell proliferation | Brain size and 1q21.1 syndrome | 62,306,307 |
NOTCH2NL | Segmental duplication | Human specific | Expressed in radial glia stem cells and tunes neuronal differentiation via NOTCH signalling | Associated with expanded neocortex, observed at breakpoints in 1q21.1 deletion/duplication syndrome | 170,171 |
NOVA1 | Single nucleotide substitution | Modern human specific | Affecting alternative splicing during nervous system development | Altering excitatory synaptic interactions and involvement in neurological disorders | 264,308 |
Regulatory element of AR (hCONDEL569) | Deletion of a highly conserved regulatory element | Human specific | Mouse and chimpanzee enhancer sequences drive lacZ expression in mouse model at facial vibrissae and genital tubercle | Potential regulation of AR expression by the loss of this regulatory element leading to loss of sensory vibrissae and penile spines | 72 |
Regulatory element of CACNA1C | Large tandem repeats | Human specific | Intronic tandem repeat array of neurodevelopmental enhancer resulting in stronger gene expression in humans | Increased expression of human CACNA1C during human neurodevelopment potentially linked to bipolar disorder and schizophrenia | 44 |
Regulatory element of CUX1 (HAR426) | Single nucleotide polymorphism | Human specific | G>A mutation within HAR426. CUX1 promoter and HAR426 interaction is likely to affect gene expression levels | Rare disease might affect dendritic spine density and synaptogenesis | 43,309 |
Regulatory element of FZD8 (HARE5) | Human accelerated enhancer | Human specific | Developmental enhancer physically interacting with FZD8 promoter | Accelerated neural progenitor cell cycle and increased neocortex size in a mouse model | 156 |
Regulatory element of GADD45G (hCONDEL332) | Deletion of a highly conserved regulatory element | Human specific | Mouse and chimpanzee enhancer sequences drive lacZ expression in the mouse ventral forebrain | Potential expansion of particular inhibitory neuron populations | 72 |
Regulatory element of GDF5–UQCC locus | Single nucleotide polymorphism | Polymorphic in human populations | Chromatin accessibility profiles of joint chondrocytes reveal positively selected regulatory variants | Affecting knee shape in humans and associated with osteoarthritis risk | 37 |
Regulatory element of LCT | Single nucleotide polymorphism | Polymorphic in human populations | Selective sweeps in the enhancer region enhance lactase expression in certain humans | Milk product digestion into adulthood (lactase persistence) and potentially other phenotypes | 24 |
Regulatory element of PPP1R17 (HAR2635 and HAR2636) | HAR | Human specific | Chromatin contact of PPP1R17 promoter and HAR2635 and HAR2636 | Acting as neurodevelopmental enhancer that may extend cell-cycle length in humans | 148 |
SIGLEC13 | Gene loss | Human specific | Alu-mediated recombination | Resistance to sialylated bacterial infections | 310,311 |
SLC22A4 | Single nucleotide polymorphism | Polymorphic in human populations | Ergothioneine transporter | Crohn’s disease, rheumatoid arthritis | 312–314 |
SLC24A5 | Single nucleotide polymorphism | Polymorphic in human populations | UV radiation-induced transporter activity | Variable skin pigmentation | 315,316 |
SLC6A11 | Single nucleotide polymorphism | Polymorphic in human populations | Single nucleotide change in a coding region | Expressed in liver and modulating triacylglycerol metabolism, potential type 2 diabetes risk factor | 317 |
SRGAP2 | Segmental duplication | Human specific | Rho GAP family member SRGAP2 paralogues expressed in the developing human cortex. SRGAP2B and SRGAP2C are truncated duplications that antagonize by dimerizing with the ancestral form of SRGAP2 | Affect dendritic spine density and morphology | 173,174,318 |
TBC1D3 | Segmental duplication | Great ape specific | Affecting neural progenitor proliferation by inhibiting histone methyltransferase G9A | Cortical expansion and folding | 319,320 |
TBXT | Intronic Alu insertion | Ape specific | Alternative splicing of TBXT | Associated with tail reduction or loss in mouse model of splicing change | 321 |
HAR, human accelerated region; hCONDEL, human conserved deletion.